Phakic intraocular lenses (IOLs), particularly the Implantable Collamer Lens (ICL), have emerged as a popular option for correcting myopia, especially in patients who are not suitable candidates ...

VISTA Eye Specialist (VISTA) is proud to announce its inclusion among Asia's Top Private Hospitals for 2025, as recognized by the prestigious Newsweek magazine. This accolade highlights VISTA's ...

TEL AVIV, Israel, January 28, 2025--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release fourth quarter 2024 results prior to the opening ...

November 25, 2024--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and ...

Check sample answers at the end of the page. News: Study finds that the number of Hong Kong children with myopia hit a record high during Covid pandemic amid more reliance on screens Chinese ...

18 EVO ICL was approved by the FDA in March 2022. The success of laser vision correction techniques such as Lasik depends on many factors, including the amount and quality of corneal tissue available ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...